Race Oncology Limited (ASX:RAC)

Race Oncology Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 12, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	235	311	200	311	527	82
Market Cap Growth	70.76%	55.59%	-35.78%	-41.00%	546.75%	1770.25%
Enterprise Value	216	297	173	274	522	80
Last Close Price	1.35	1.82	1.23	1.95	3.67	0.70
PS Ratio	44.63	77.63	63.73	439.48	1360.92	511.48
PB Ratio	11.32	16.97	7.84	8.62	38.42	14.33
P/TBV Ratio	13.00	20.05	8.92	9.50	52.37	46.49
EV/Sales Ratio	41.06	74.21	55.32	387.06	1346.52	501.76
Asset Turnover	0.25	0.17	0.10	0.03	0.04	0.03
Quick Ratio	20.39	9.26	20.16	23.71	18.07	7.30
Current Ratio	20.59	9.32	20.44	24.10	20.24	8.20
Return on Equity (ROE)	-37.20%	-63.10%	-32.22%	-44.96%	-65.32%	-71.62%
Return on Assets (ROA)	-24.05%	-38.63%	-20.41%	-27.05%	-39.39%	-43.96%
Return on Capital (ROIC)	-24.99%	-41.34%	-21.26%	-28.10%	-40.95%	-45.75%
Earnings Yield	-3.26%	-4.45%	-4.97%	-3.60%	-1.20%	-4.72%
Buyback Yield / Dilution	-4.44%	-2.35%	-4.83%	-17.06%	-22.86%	-33.50%

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.